NCT05561673: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years |
|
|
| Recruiting | 1 | 150 | Europe | GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, Engerix-B, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, Fendrix, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2 | GlaxoSmithKline | Hepatitis B | 03/24 | 01/25 | | |
